In respect of the Goods requested in any Order, Dynavax shall invoice the Customer ​ of the aggregate price of the Goods covered by an Order upon acceptance of such Order (which, except as otherwise provided in [Annex A] of the Agreement, shall be placed six (6) months in advance of delivery date in such Order) from Customer.

For the Services rendered pursuant to Article 3, Article 4 or Article 5, the BFA Recipient (or BFA, on behalf of the BFA Recipient) agrees to pay to Provider the fees and expenses set forth in [Schedule 1]-C (Commercial Terms Schedule) to this Agreement (the “Fees”). Unless otherwise agreed in [Schedule 1]-C (Commercial Terms Schedule), Provider will be responsible for the compensation of all Subcontractors and its other agents (in each case, to the extent selected by Provider).

Invoicing and Payment. All fees shall be payable in accord with payment provisions specified in the Exhibits that describe Programs or Services and shall be deemed overdue if such fees remain unpaid after the applicable due date for any such fees. Failure to pay any material, undisputed portion of any fee when due shall constitute a material breach of this Agreement.

Invoicing; Payment. [[Bachem CH:Organization]] shall provide Apellis with an Invoice for each Batch of Drug Substance Delivered against a Firm Order placed by Apellis in accordance with this Agreement, which will be based on the then current Supply Price. Such Invoices shall be delivered electronically to ​ upon release of a batch. Apellis shall pay each Invoice within ​ from the date the Invoice is delivered. All payments under this Agreement shall be made in U.S. Dollars by wire transfer into an account designated by the receiving Party.

Invoicing and Payment. In addition to the costs described in Sections 4 and 55] above for which a Party is responsible, each Party shall submit a statement to the other Party of the percentage of each of its employees’ time utilized in performing Services for the other Party on a quarterly basis. Each Party shall pay the other Party a fee calculated as the annual base salary of each employee providing Services pursuant to this Agreement multiplied by the percentage of time for each such employee submitted in the quarterly statement. The Parties shall evaluate the costs associated with the provision of the Services on an annual basis or more frequently if warranted by a change in circumstances and if such evaluation results in a change in the cost of the Services, the requesting Party shall provide written notification of the change to the other Party, and the change in the cost of the Services shall go into effect the following calendar quarter after the provision of such notice. Each Party shall submit its written statement to the other Party quarterly for the cost of Services, as determined under this Section 7, as well as the costs described in Sections 4 and 55] above for which the other Party is responsible. The invoiced Party shall pay the invoicing Party within thirty (30) days of receipt of such statement. Payment may be effected by netting each Party’s invoice. If at any time during the Initial Term or Renewal Term, the Parties share the services of a common agent or contractor to manage their respective treasury and accounting functions, that agent or contractor shall be authorized to record the appropriate payable and receivable on the accounts maintained for the parties in lieu of the invoicing and payments required under this Agreement.

Invoicing and Payment. Licensee shall give [[AstraZeneca:Organization]] written notice of the achievement of each milestone event in [Section 4.2.1] (Development Milestones) or [Section 4.2.2] (Commercial Milestones) no later than ​ Business days after learning such achievement (and subject to the timing for Commercial Milestone Events as set forth in [Section 4.2.3]). Following receipt of such notice, [[AstraZeneca:Organization]] shall submit an invoice to Licensee for the full amount of the corresponding milestone, which amount shall be payable within ​ days of the date of invoice.

Invoicing and Payment Due. [Schedule 1]-C (Commercial Terms Schedule) and this Section 9.4 set forth the invoicing and payment terms and procedures associated with the charges payable to Provider for performance of the Services. Provider will include on each invoice the calculations used to establish the charges therein.

Invoicing. Upon receipt of SYROS’s acceptance or upon expiration of the ​ review period as described above, QIAGEN shall issue an invoice to SYROS for the relevant Milestone Payment and send such invoice to the following address: ​

Invoicing and Payment. RUS shall invoice AssetMark monthly in arrears by electronic invoice for all applicable charges. Except for the Conversion Period charges, no invoice shall include estimated charges, but only actual charges. If payment of undisputed amounts is not received by RUS within thirty (30) days after the receipt by AssetMark of the RUS electronic transmission of the invoice, RUS shall provide AssetMark written notice of the same. If AssetMark does not pay any undisputed amount owed to RUS within five (5) days after the date such notice is deemed given pursuant to Section 23(b), AssetMark agrees to pay RUS interest on the unpaid and undisputed balance at the rate of one percent (1%) per annum from the date of electronic transmission of the invoice until paid in full.

As set forth in the CSA, Evoke will invoice Eversana’s [[Unknown Identifier]] division for Products at ​, or an otherwise agreed upon rate established by the Joint Management Committee. The invoice for all Products purchased during the first ​ after commercial launch of the Product shall be due ​ from the date of the invoice. All invoices thereafter shall be due ​ from the date of the invoice. Eversana agrees that for each sale of Products from Evoke to Eversana, Eversana will issue a resale certificate to Evoke indicating that Eversana will only resell the Products as approved by the Joint Management Committee.